Biden-Harris Administration Announces Medicare Advantage and …

Nov 26, 2024 · Today, the Centers for Medicare & Medicaid Services (CMS) is proposing actions in the Medicare Advantage (MA) and Medicare Part D prescription drug programs to continue …

CouponFollow Extension

$25
OFF

7.4 Million Americans Could Gain Medicare Or Medicaid Coverage …

3 weeks from now

Nov 26, 2024 · The Medicare coverage expansion would cost an estimated $25 billion over a decade and should not have a short-term impact on drug plan premiums, Meena Seshamani, …

cnn.com

FAQs about Biden-Harris Administration Announces Medicare Advantage and … Coupon?

What does Cy 2026 mean for Medicare?

The Contract Year (CY) 2026 MA and Part D proposed rule aims to hold MA and Part D plans more accountable for delivering high-quality coverage so that people with Medicare are connected to the care they need when they need it. ...

Which Medicare programs will be revised in 2024?

Background On November 26, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would revise the Medicare Advantage (MA) Program, Medicare Prescription Drug Benefit Program (Part D), Medicare Cost Plan Program, Programs of All-Inclusive Care for the Elderly (PACE). ...

Does Medicare cover anti-obesity medications?

In recognition of the prevailing medical consensus that obesity is a disease, CMS is proposing to reinterpret the statute to no longer exclude anti-obesity medications for the treatment of obesity from coverage under Medicare Part D and to require Medicaid programs to cover these medications when used to treat obesity. ...

Will Medicare cover obesity drugs in 2026?

Under a rule proposed by the U.S. Department of Health and Human Services, the Biden administration estimates that 3.4 million Americans on Medicare would be eligible for the drugs beginning in 2026, which can retail for over $1,000 a month. While some states currently cover obesity drugs for Medicaid enrollees, most do not. ...

How much would anti-obesity drugs cost Medicare & Medicaid?

The proposed rule would make an estimated 4 million Medicaid recipients eligible for coverage. Centers for Medicare & Medicaid officials estimated the anti-obesity drugs would cost Medicare and Medicaid about $40 billion over a decade. States would be expected to pay for about $3.8 billion of that total amount for Medicaid enrollees. ...

Will Medicare reinterpret Medicare coverage for anti-obesity medications?

The proposed reinterpretation would also apply to the Medicaid program. The proposed reinterpretation of Medicare coverage for anti-obesity medications (AOMs) is a critical inflection point in how the federal government approaches the treatment of obesity. ...